What This Means
This research suggests that the small cellular compartments called lysosomes — which act as the cell's waste disposal and recycling system — play an important role in the deterioration of spinal discs, a condition called intervertebral disc degeneration (IVDD). By analyzing gene activity data from human disc tissue samples and combining several computational methods, the researchers found that patients with disc degeneration could be grouped into two distinct biological subtypes: one characterized by cellular aging and inflammation, and another by altered metabolism. Both subtypes showed signs of lysosomal dysfunction, and the degree of lysosomal gene activity was closely linked to markers of cellular aging, suggesting these processes are coordinated rather than independent.
The study also identified four specific genes — HYAL1, MMD, PLD3, and ANK3 — as likely key players in this lysosomal dysfunction. Experiments in disc cells grown in the laboratory showed that reducing the activity of one of these genes, PLD3, made cells more vulnerable to damage, speeding up lysosomal breakdown, tissue matrix deterioration, and cellular aging. Conversely, increasing PLD3 activity had protective effects, supporting its role in maintaining lysosomal health.
Finally, the researchers tested a naturally occurring compound called lithocholic acid (LA) as a potential treatment. In laboratory cell experiments and in a rat model of disc degeneration, LA partially restored lysosomal function, improved the cells' ability to clear waste through autophagy, and reduced signs of tissue degeneration. This research suggests that targeting lysosomal function — particularly through agents like lithocholic acid or by modulating genes like PLD3 — could represent a new avenue for treating intervertebral disc degeneration, though further studies would be needed to translate these findings to clinical use.